US claims data show patients with generalized pustular psoriasis (GPP) face up to a 4-fold higher mortality risk compared ...

For many people with psoriasis, there are bad hair days — and then there are really bad hair days, complete with itchy, flaking scalp psoriasis that can look as icky as it feels. Scalp ...

At least twice as many patients on the approved spesolimab dose maintain improvement in skin symptoms and quality of life ...

Background: Psoriasis is a chronic inflammatory skin disease with a genetic predisposition and autoimmune component, often treated with immunomodulators such as biologic therapies. Objectives: In this ...

You may face a higher risk of developing a Candida fungus infection if you have psoriasis. This can make your psoriasis symptoms worse. It can also lead to other health issues, such as thrush or ...

Whether you suffer from psoriasis yourself or have heard about it from a famous Kardashian who has been very transparent about her symptoms, you know that the skin condition is far from glamorous and ...

GPP is a rare and severe form of psoriasis. There is no licensed standard care for GPP flares. Current treatment options include ciclosporin, acitretin, and biologics used for other psoriasis types.

After considering the feedback from consultation, the appraisal committee has prepared final draft guidance (FDG) on spesolimab for treating generalised pustular psoriasis flares and submitted it to ...

Arcutis convened the Genital Psoriasis Wellness Consortium, a multidisciplinary group of clinicians who are experts in their fields Publication includes 14 consensus statements aimed at improving ...

Additionally, some infections may exacerbate or trigger psoriasis, such as strep throat. Regardless of whether you are on a biologic or immunosuppressive medication for psoriasis, it’s essential ...

Icotrokinra showed rapid efficacy among adults and adolescents with at least moderate psoriasis. Most participants with scalp psoriasis treated with icotrokinra achieved the study’s primary ...

Psoriasis is a chronic inflammatory disorder for which phosphodiesterase-4 (PDE4) inhibitors have emerged as promising therapeutic agents due to an ability to regulate inflammatory signaling pathways.